| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Culley Brian M | President and CEO, Director | C/O LINEAGE CELL THERAPEUTICS, 2173 SALK AVENUE, SUITE 200, CARLSBAD | /s/ Brian M. Culley | 19 Dec 2025 | 0001310683 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LCTX | Common Shares | Award | +8,925 | +4.2% | 222,469 | 19 Dec 2025 | Direct | F1, F2 | ||
| transaction | LCTX | Common Shares | Tax liability | $561 | -334 | -0.15% | $1.68 | 222,135 | 19 Dec 2025 | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | Shares earned by the Reporting Person upon the vesting of a portion of restricted stock units ("RSUs") granted to the Reporting Person on February 11, 2022 the vesting of which was subject to the achievement of certain performance conditions. RSUs are settled in common shares on a one-for-one basis. |
| F2 | Does not include RSUs that may be settled in the issuer's common shares that have not vested as of the date hereof nor common shares that may be acquired upon the exercise of certain stock options outstanding as of the date hereof. |
| F3 | Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 8,925 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction. |